Source:http://linkedlifedata.com/resource/pubmed/id/10669863
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2 Pt 1
|
pubmed:dateCreated |
2000-3-31
|
pubmed:abstractText |
Venom immunotherapy rapidly reduces the risk of a systemic sting reaction in adults from 30% to 70% to less than 2%. When venom immunotherapy is stopped after 5 years or longer, the risk of a systemic sting reaction is 5% to 15% during the first few years after stopping treatment. It is uncertain whether systemic sting reactions will occur more than 5 years after discontinuing venom immunotherapy and whether treatment can be safely stopped in some patients after less than 5 years.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0091-6749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
105
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
385-90
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10669863-Adult,
pubmed-meshheading:10669863-Anaphylaxis,
pubmed-meshheading:10669863-Animals,
pubmed-meshheading:10669863-Desensitization, Immunologic,
pubmed-meshheading:10669863-Follow-Up Studies,
pubmed-meshheading:10669863-Humans,
pubmed-meshheading:10669863-Hymenoptera,
pubmed-meshheading:10669863-Insect Bites and Stings,
pubmed-meshheading:10669863-Risk Factors,
pubmed-meshheading:10669863-Time Factors,
pubmed-meshheading:10669863-Treatment Outcome,
pubmed-meshheading:10669863-Venoms
|
pubmed:year |
2000
|
pubmed:articleTitle |
Survey of patients after discontinuing venom immunotherapy.
|
pubmed:affiliation |
Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|